Skip to content

Study for the Syndrome Specification and Syndrome Element Characteristics of Gastric Cancer Guided by Metabonomics and the Intervention Effect of Jianpi Yangzheng Xiaozheng Method

Study for the Syndrome Specification and Syndrome Element Characteristics of Gastric Cancer Guided by Metabonomics and the Intervention Effect of Jianpi Yangzheng Xiaozheng Method

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020782
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Group 2:TCM Syndrome Differentiation Treatment + Chemotherapy

Sponsors

Yangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Pathological diagnosis conforms to the diagnostic criteria of gastric cancer; (2) advanced patients who cannot undergo radical surgery or have definite recurrence and metastasis after surgery, but cannot be treated surgically; (3) the estimated survival time is more than three months; (4) understanding the situation of this study and signing the informed consent, and obtaining the informed consent should comply with the GCP requirements.

Exclusion criteria

Exclusion criteria: Those who can not eat through mouth (including gastrointestinal obstruction and jejunostomy); those who have brain metastasis; and those who have serious primary cardiovascular disease, liver disease, kidney disease and hematological disease.

Design outcomes

Primary

MeasureTime frame
Plasma metabolite group;Overall survival time;Quality of life score;

Contacts

Public ContactZhang Xiaochun

Yangzhou Hospital of Traditional Chinese Medicine

ceiq@sina.com+86 13901453036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026